Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT00333294
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent.
* 18 to 75 years inclusive.
* At least one measurable lesions histologically confirmed inoperable stage III NSCLC.
* WHO performance status of 0 to 2 inclusive.
* Adequate pulmonary function, pulmonary dose volume histogram less than or equal to 40 %.
* Life expectancy of at least 6 months.
* Using secure contraceptives precautions.
Exclusion Criteria:
* Any previous anti cancer therapy for NSCLC.
* Known severe hypersensitivity to these products
* Any evidence of clinically active interstitial lung disease
* Other co-existing malignancies, symptomatic metastases.
* Abnormal blood test
* Weight loss of over 15% in the 3 months before the start of the study.
* Treatment with a non-approved or investigational drug within 30 days before Day 1 of study treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00333294
Study Brief:
Protocol Section:
NCT00333294